Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056411

10% owner sold 13,531 shares at an average $29.17 ($394,635)

From the SEC's structured data for this filing

Trades in this filing

UBS Oncology Impact Fund L.P. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-14 Sale : show line 1 in the form −7,106 $29.17 $207,282 7,657,817 D
2021-09-15 Sale : show line 2 in the form −6,425 $29.16 $187,353 7,651,392 D
Open-market sales · 13,531 sh · avg $29.17 · $394,635
Loading xslF345X03/doc4.xml…